AdobeStock_233949974[1]

Posts in Germany

Featured

Sysmex Inostics OncoBEAM™-EGFR Digital PCR Liquid Biopsy Demonstrates Two-fold Higher Detection of p.T790M Mutations in 183 NSCLC Patients in Comparison Study

Read More →

Sysmex Inostics' SafeSEQ ER+/HER2- Breast Cancer Panel Demonstrates Equivalent Sensitivity to OncoBEAM™ Enhanced Digital PCR Technology for Detection of Mutations in Circulating Tumor DNA

May 28, 2019 1:45:00 PM
3 min read

Sysmex Inostics´ OncoBEAM™ demonstrates clinical validity and superior performance versus pan-cancer NGS for blood-based mutation detection for hepatocellular carcinoma

Feb 25, 2019 1:22:00 PM
3 min read

Sysmex Inostics´ OncoBEAM™ circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers

Germany
Nov 5, 2018 1:26:00 PM
4 min read

1 min read

1 min read

Subscribe for Blog Updates
Contact Us

Information in accordance with Art. 13 GDPR: https://www.sysmex-inostics.com/data

Germany: Sysmex Inostics GmbH, Falkenried 88, D-20251 Hamburg, Germany. +49 40- 325907-0

United States: Sysmex Inostics, Inc., 1812 Ashland Ave Suite 500, Baltimore, Maryland 21205, USA.   +1-855-BEAM-DNA (232-6362)

Japan: Sysmex Corporation, 1-5-1 Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan.   +81 78 265-0500
Copyright © Sysmex Inostics, All Rights Reserved.